Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive

Fig. 1

In vitro cytotoxicity of CPI/BPA (1:5) (a), CPI/BPA-NP (1:2) (c), CPI/BPA (1:1) (e), CPI/BPA (2:1) (g), CPI/BPA (5:1) (i) against Hepa1–6 cells, determined by MTT assays; CI versus Fa plots for CPI/BPA (1:5) (b), CPI/BPA-NP (1:2) (d), CPI/BPA (1:1) (f), CPI/BPA (2:1) (h) and CPI/BPA (5:1) (j); Synthesis process of BCP nanoparticles (k); TEM images of BCP NPs (l); size distribution of BCP NPs measured by DLS (m); Zeta potentials of Blank PLGA NPs and BCP NPs (n); XRD of CPI-613,3-BPA, Blank PLGA NPs and CBP NPs (o); Cumulative Release of Cy-7 (p) and Coumarin (q) in PLGA NPs

Back to article page